These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1376759)

  • 1. [Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
    Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y; Sezaki H; Ohta M; Nakanishi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):341-8. PubMed ID: 1376759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
    Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer].
    Umeki H; Yamaguchi Y; Tsugata M; Wakana K; Somekawa Y; Shimabukuro K; Ohara M; Terauchi T; Ichimura M; Otsuka I; Aso T
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):377-82. PubMed ID: 12669397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer.
    Hirabayashi K; Okada E
    Cancer; 1993 May; 71(9):2769-75. PubMed ID: 7682148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long time survival after combination chemotherapy with cisplatin, vinblastine and peplomycin for cervical cancer].
    Onishi Y; Hatae M; Hokanishi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jul; 45(7):657-64. PubMed ID: 7688016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
    Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
    Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
    Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ifosfamide in cervical cancer.
    Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
    Singhal RM; Jindel R; Gupta AK
    Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant chemotherapy for advanced cervical cancer].
    Kodama J; Ikuhashi H; Hongo A; Mizutani Y; Miyagi Y; Yoshinouchi M; Kobashi Y; Okuda H; Kudo T
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):89-92. PubMed ID: 9987503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1050-5. PubMed ID: 2693187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, 5-fluorouracil, and ifosfamide in the treatment of recurrent or advanced cervical cancer.
    Fanning J; Ladd C; Hilgers RD
    Gynecol Oncol; 1995 Feb; 56(2):235-8. PubMed ID: 7896191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
    Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
    Yasui Y; Suzumori K; Asai H; Yagami Y
    Gan No Rinsho; 1985 Sep; 31(11):1415-21. PubMed ID: 2415720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
    Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.